Steroids in Cerebral Palsy: Contraindications and Considerations
Steroids are not contraindicated in cerebral palsy as a condition itself, but their use requires careful consideration of specific circumstances, comorbidities, and treatment goals.
General Principles for Steroid Use in Cerebral Palsy
Cerebral palsy (CP) is not a direct contraindication to steroid therapy. However, several important considerations should guide their use:
When Steroids May Be Indicated in CP Patients:
Acute Neurological Conditions:
Inflammatory Conditions:
Specific Contraindications and Cautions:
Guillain-Barré Syndrome:
- Steroids are specifically not recommended in idiopathic GBS 1
- IVIG or plasmapheresis are preferred treatments
Postnatal Use in Premature Infants:
Relative Contraindications:
- Uncontrolled hypertension
- Uncontrolled diabetes
- Acute peptic ulcer
- Severe behavioral symptoms that may worsen with steroid therapy 1
Decision Algorithm for Steroid Use in CP Patients
Assess the primary indication:
- Is the steroid being used to treat CP itself? (Generally not indicated)
- Is it for a concurrent condition? (May be appropriate)
Evaluate risk factors:
- Age (pediatric vs adult)
- Comorbidities (diabetes, hypertension, etc.)
- Current medications and potential interactions
- History of steroid response/side effects
Consider alternative treatments:
- For neurological conditions like GBS, consider IVIG or plasmapheresis instead 1
- For joint pain, consider non-steroidal options first
If steroids are indicated:
Special Considerations in Pediatric CP Patients
Children with CP require additional considerations:
- Evidence for steroid use in pediatric Bell's palsy is less robust than in adults 1, 4
- All children with Bell's palsy in one study recovered with or without steroid treatment 4
- Postnatal steroid exposure in premature infants significantly increases CP risk 3
- Benefit-harm assessment must be carefully weighed in each case
Conclusion
While cerebral palsy itself is not a contraindication to steroid therapy, the decision to use steroids in patients with CP should be based on the specific indication, potential benefits, and risks. For certain conditions like Bell's palsy and autoimmune encephalitis, steroids may be appropriate despite the presence of CP. However, for conditions like Guillain-Barré syndrome, steroids should be avoided. The most important consideration is to evaluate each case individually based on the specific neurological condition being treated and the patient's overall clinical picture.